检索

Features of clinical, functional and hemodynamics profile, medical treatment and prognosis evaluation in patients with inoperable chronic thromboembolic pulmonary hypertension and idiopathic pulmonary arterial hypertension according to the Russian registry

Chazova I., Valieva Z., Nakonechnikov S., Taran I., Martynyuk T.

(Rus)

卷 94, 编号 7 (2022)

Chronic kidney disease in outpatients with arterial hypertension: clinical characteristics and treatment efficacy (according to the national registry)

Oschepkova E., Aksenova A., Orlovsky A., Chazova I.

(Rus)

卷 92, 编号 3 (2020)

Socio-economic burden of pulmonary hypertension: relevance of assessment in Russia and the world

Zakiev V., Gvozdeva A., Martynyuk T.

(Rus)

卷 79, 编号 9 (2004)

Arterial hypertension in chronic glomerulonephritis:detectability and treatment efficacy

Kutyrina I., Martynov S., Shvetsov M., Livshits N., Miroshnichenko N., Golitsina E., Varshavsky V.

卷 92, 编号 9 (2020)

The achievements of the modern specific therapy of pulmonary arterial hypertension and chronic thromboembolic pulmonary hypertension: focus on the stimulator of soluble guanylate cyclase riociguat

Gratsianskaya S., Valieva Z., Martynyuk T.

(Rus)

卷 91, 编号 12 (2019)

A systematic review as a method of gathering scientific evidence into clinical guidelines: CHEST-2019 guideline for the therapy pulmonary arterial hypertension in adults

Shmalts A., Gorbachevsky S.

(Rus)

卷 95, 编号 12 (2023)

Chronic thromboembolic pulmonary hypertension: current diagnostic and treatment options: A review

Chazova I.

(Rus)

卷 91, 编号 1 (2019)

Clinical features of arterial hypertension in men and women (according to the National Registry of Arterial Hypertension)

Chazova I., Aksenova A., Oschepkova E.

(Rus)

卷 78, 编号 2 (2003)

Albarel (rilmenidin) - a selective agonist of imidazol receptors. II. Pharmacological properties and experience of clinical use

Khirmanov V.

卷 93, 编号 9 (2021)

Evidence base for specific pulmonary vasodilators in adults with congenital heart disease

Shmalts A., Gorbachevsky S.

(Rus)

卷 92, 编号 12 (2020)

Advantages and limitations of initial combination therapy in pulmonary arterial hypertension patients in Russia

Shmalts A., Gorbachevsky S.

(Rus)

Antihypertensive therapy in men and women in real clinical practice according to the National register

Oshhepkova E., Aksenova A., Orlovskij A., Chazova I.

(Rus)

卷 85, 编号 1 (2013)

Results of implementation of a hypertension control program in Russia in 2002-2012

Chazova I., Oshchepkova E.

卷 94, 编号 7 (2022)

Rehabilitation in patients with chronic thromboembolic pulmonary hypertension

Sagaydak O., Danilov N., Chazova I.

(Rus)

卷 94, 编号 1 (2022)

The incidence of cardiovascular and cerebrovascular complications in patients with uncontrolled hypertension

Denisova A., Solntseva T., Zarmanbetova A., Tkacheva A., Sivakova O., Chazova I.

(Rus)

卷 90, 编号 3 (2018)

Combination therapy is a new standard for treatment of pulmonary arterial hypertension

Avdeev S., Tsareva N., Gaisin I.

(Rus)

卷 90, 编号 4 (2018)

New horizons for the use of the second generation of endothelin receptor antagonist macitentan in patients with pulmonary hypertension

Martynyuk T., Nakonechnikov S., Chazova I.

(Rus)

卷 87, 编号 1 (2015)

Impact of bosentan therapy on stress-induced pulmonary hypertension in patients with systemic sclerosis

Volkov A., Kurmukov I., Iudkina N., Glukhova S., Nikolaeva E.

卷 86, 编号 9 (2014)

Pulmonary hypertension in Russia: The first results of the national register

Chazova I., Arkhipova O., Valieva Z., Nakonechnikov S., Martyniuk T.

卷 84, 编号 4 (2012)

CURRENT RECOMMENDATIONS ON DIAGNOSIS AND TREATMENT OF PULMONARY ARTERIAL HYPERTENSION

Avdeev S.

卷 94, 编号 4 (2022)

A rare clinical case of the patient with pulmonary hypertension associated with hereditary hemorrhagic telangiectasia. Case report

Kasparova A., Valieva Z., Martynyuk T.

(Rus)

Renal denervation with a resistant arterial hypertension: the results of a five-year follow-up

Glybochko P., Svetankova A., Rodionov A., Maltseva A., Sulimov V., Fomin V.

(Rus)

卷 90, 编号 1 (2018)

Perspectives of using pulmonary arterial stiffness indicators to evaluate the prognosis of patients with pulmonary arterial hypertension

Simakova M., Ryzhkov A., Kazymly A., Naimushin A., Lukinov V., Moiseeva O.

(Rus)

卷 97, 编号 7 (2025)

Clinical portrait and features of antihypertensive therapy in comorbid patients with arterial hypertension and chronic obstructive pulmonary disease according to the national hypertension registry

Aksenova A., Serov I., Belova O., Rachkova S., Chazova I.

(Rus)

卷 93, 编号 1 (2021)

Refractory and resistant hypertension in patients with type 2 diabetes mellitus: differences in metabolic profile and endothelial function

Falkovskaya A., Mordovin V., Pekarskiy S., Ripp T., Manukyan M., Lichikaki V., Zyubanova I., Sitkova E., Gusakova A., Ryabova T.

(Rus)

卷 91, 编号 3 (2019)

Comparison of the integral indices of the vectorcardiogram with the data of echocardiography in patients with idiopathic and chronic thromboembolic pulmonary hypertension

Sakhnova T., Blinova E., Belevskaya A., Saidova M., Arkhipova O., Yurasova E., Alokova F., Martynyuk T., Chazova I.

(Rus)

卷 97, 编号 3 (2025): Пульмонология

Historical milestones in the study of pulmonary hypertension

Osokina A., Rodnenkov O., Martynyuk T.

(Rus)

卷 95, 编号 4 (2023)

Applying of magnetic resonance tomography for assessment of cardiac remodeling and risk stratification in patients with pulmonary arterial hypertension

Shariya A., Martynyuk T., Shariya M., Ustyuzhanin D.

(Rus)

Endothelial dysfunction in patients with controlled and uncontrolled arterial hypertension

Podzolkov V., Safronova T., Natkina D.

(Rus)

卷 91, 编号 3 (2019)

Arterial hypertension and chronic obstructive pulmonary disease: clinical characteristics and treatment efficasy (according to the national register of arterial hypertension)

Chazova I., Lazareva N., Oshchepkova E.

(Rus)

Features of the clinics and treatment of patients with obesity and hypertension (according to the National register of arterial hypertension)

Oshchepkova E., Lazareva N., Chazova I.

(Rus)

卷 85, 编号 12 (2013)

Role of the endothelin receptor antagonist bosentan in the treatment of patients with pulmonary hypertension

Tsareva N.

卷 85, 编号 3 (2013)

Psychosomatic relationships in postmenopausal women

Lareva N., Govorin A.

卷 84, 编号 11 (2012)

Metabolic disturbances as a factor of the pathogenesis of hypertensive disease and its clinical outcomes

Kovalenko V., Talaeva T., Shumakov V., Bratus' V.

卷 84, 编号 4 (2012)

LEFT ATRIAL DEFORMATION IN HYPERTENSIVE PATIENTS WITH AORTIC STENOSIS AND LEFT VENTRICULAR HYPERTROPHY OF DIFFERENT SEVERITY

Kalinin A., Alekhin M., Bachs G., Leinieks A., Kalninsh S., Schipachov P.

卷 83, 编号 10 (2011)

Low-dose combination of perindopril arginine with indapamide in correction of metabolic syndrome

Kseneva S., Borodulina E., Semiglazova T., Kulakova N., Tarasova I., Udut V., Kseneva S., Borodulina E., Semiglazova T., Kulakova N., Tarasova I., Udut V.

卷 83, 编号 4 (2011)

A protective effect of Gly272Ser polymorphism of GNB3 gene in development of essential hypertension and its relations with environmental hypertension risk factors

Polonikov A., Solodilova M., Ivanov V., Shestakov A., Ushachev D., Vyalykh E., Vasil'eva O., Polyakova N., Antsupov V., Kabanina V., Kupriyanova Y., Bulgakova I., Kozhukhov M., Tevs D., Polonikov A., Solodilova M., Ivanov V., Shestakov A., Ushachev D., Vyalykh E., Vasilyeva O., Polyakova N., Antsupov V., Kabanina V., Kupriyanova Y., Bulgakova I., Kozhukhov M., Tevs D.

卷 83, 编号 2 (2011)

Fundoplication as prophylaxis of reflux-esophagitis in patients with varicose esophageal veins

Vasnev O., Yanova O., Kovyazina I., Vasnev O., Yanova O., Kovyazina I.

卷 82, 编号 9 (2010)

Trends in subclinical atherosclerosis in patients with arterial hypertension associated with diabetes mellitus: a relationship between the blood pressure achieved with antihypertensive therapy and the body weight

Karpov O., Koshel'skaya R., Khoroshilova I., Karpov R., Koshelskaya O., Khoroshilova I.

卷 81, 编号 9 (2009)

Treatment of patients with arterial hypertension and other stroke risk factors in clinical practice. The PROGNOS program

Bubnova M., Oganov R., Bubnova M., Oganov R.

卷 81, 编号 6 (2009)

Affection of target organs in hypertensive patients with and without metabolic syndrome

Sharipova G., Saidova M., Balakhonova T., Mychka V., Chazova I., Sharipova G., Saidova M., Balakhonova T., Mychka V., Chazova I.

卷 81, 编号 4 (2009)

Quantitative repolarization indices in diagnosis of left ventricular hypertrophy in hypertensive patients

Sakhnova T., Blinova E., Sergakova L., Ataullakhanova D., Chazova I., Sakhnova T., Blinova E., Sergakova L., Ataullakhanova D., Chazova I.

卷 79, 编号 11 (2004)

Lisinopril effects on cerebral blood flow and blood rheology in hypertensive patients

Markova L., Kuznetsova I., Radzevich A.

Polymorphic markers of GNB3 (C825T), AGTR1 (A1166C) and ACE (A2350G and I/D) genes in patients with arterial hypertension combined with diabetes mellitus type 2

Karpov R., Puzyrev K., Koshelskaya О., Makeeva O., Suslova T., Efimova E., Falkovskaya A., Atroshenkov A.

卷 78, 编号 11 (2003)

Impact of long-term antihypertensive therapy on the vasoregulating function of the brachial artery in patients with arterialhypertension associated with type 2 diabetes mellitus

Karpov R., Koshelskaya O., Falkovskaya A., Ocheredko N., Atroshenkov A., Makarova Y.

卷 78, 编号 6 (2003)

Telmisartan (micardis) - an antagonist of angiotensin II receptors of type 1: one more antihypertensivedrug or something greater?

Chazora I.

卷 78, 编号 4 (2003)

Current diagnostic and therapeutic aspects of symptomatic arterial hypertension of adrenal genesis

Shevchenko Y., Vetshev P., Podzolkov V., Ippolitov L., Rodionov A., Polunin G.

卷 96, 编号 11 (2024): Инфекционные заболевания

Long-COVID, severe course, with congenital bronchiectasis, Williams–Campbell syndrome. Case report

Pribylov S., Maslova T., Pribylov V., Leonidova K., Pribylova N., Kuts A.

(Rus)

卷 95, 编号 9 (2023)

Relationship between the pain severity, use of non-steroidal anti-inflammatory drugs and blood pressure in elective large joint arthroplasty of the lower extremities

Okisheva E., Mironova O., Berdysheva M., Pyatigorets E., Krivova N., Kurnosova A., Elizarov M., Smetanin S., Lychagin A., Fomin V.

(Rus)

卷 94, 编号 9 (2022)

"Guiding lights" for the diagnosis of chronic thromboembolic pulmonary hypertension in the flow of patients with pulmonary embolism

Chazova I., Martynyuk T., Gorbachevskii S., Gramovich V., Danilov N., Panchenko E., Chernyavskiy A., Shmalts A., Yavelov I.

(Rus)

卷 94, 编号 2 (2022)

The development of portal hypertension and liver failure on the background of long-term intake of vitamin A in a young woman. Case report

Arisheva O., Avdoshina S., Goreva L., Markova M.

(Rus)

卷 93, 编号 9 (2021)

Tactics of antihypertensive therapy during COVID-19 pandemic

Podzolkov V., Bragina A., Rodionova Y., Bragina G., Bykova E.

(Rus)

卷 93, 编号 6 (2021)

Assessment of the influence of different factors on the risk of the development of a new coronavirus infection in patients with contrast induced acute kidney injury

Isaev G., Mironova O., Fomin V.

(Rus)

卷 93, 编号 1 (2021)

Blood pressure telemonitoring and remote counseling in uncontrolled hypertension

Ionov M., Zhukova O., Zvartau N., Konradi A.

(Rus)

卷 91, 编号 8 (2019)

Patient's way from acute pulmonary embolism to chronic thromboembolic pulmonary hypertension: diagnostic and treatment options

Edemskiy A., Ivanov S., Kliver E., Novikova N., Galstyan M., Sevastyanov A., Cherniavsky A.

(Rus)

卷 78, 编号 8 (2003)

Efficacy and safetyof different p-blockers in patients with isolated systolic hypertension, associated with diabetes mellitus and obstructive pulmonary diseases

Kukes V., Ostroumova O., Mamaev V., Batutina A., Abakumov Y., Zykova A.

Vitamin D deficiency and cardiovascular pathology

Podzolkov V., Pokrovskaya A., Panasenko O.

(Rus)

Arterial hypertension in the light of current recommendations

Chazova I.

(Rus)

卷 90, 编号 12 (2018)

The effectiveness of combination antihypertensive therapy in patients with arterial hypertension and additional risk factors: obesity and obstructive sleep apnea syndrome

Elfimova E., Litvin A., Chazova I.

(Rus)

(Rus)

卷 90, 编号 1 (2018)

Realities and prospects of remote blood pressure monitoring in hypertensive patients

Boytsov S.

(Rus)

A fixed-dose lisinopril+amlodipine+rosuvastatin combination: prospects for its use in patients with hypertension and concomitant dyslipidemia

Podzolkov V., Bragina A., Osadchiy K.

Clinical value of the determination of markers for endothelial dysfunction (endothelin-1, microalbuminuria) and tubulointerstitial tissue lesion (Β2-microglobulin, monocyte chemotactic protein-1) in hypertensive patients with uric acid metabolic disorders

A retrospective historical study evaluating the safe use of current antidepressants in cardiology practice

Ivanov S., Volel B., Syrkina E., Ternovaya E., Troshina D., Grubova M., Tolkacheva I., Rozhkov A., Simonov A.

(Rus)

卷 89, 编号 2 (2017)

Elastography in the diagnosis of portal hypertension in patients with liver cirrhosis

Liusina E., Pavlov C., Ivashkin V.

(Rus)

卷 88, 编号 11 (2016)

Evaluation of the pharmacoeconomic efficacy of prestance in the treatment of hypertensive patients on the basis of the results of the POTENTIAL program

Dyakov I., Glezer M.

(Rus)

卷 88, 编号 8 (2016)

Possibility of evaluating the effectiveness of renal artery sympathetic denervation in resistant hypertension early after radiofrequency ablation

Rebrova T., Ripp T., Afanasiev S., Mordovin V., Muslimova E.

(Rus)

卷 87, 编号 8 (2015)

Chronic obstructive pulmonary disease concurrent with hypertension: Evaluation of the therapeutic effect of prolonged-release indapamide

Ovcharenko S., Morozova T., Nersesyan Z.

卷 87, 编号 4 (2015)

Prognostic value of risk factors for cardiovascular diseases and target organ damages for the occurrence of resistant hypertension

Lazutkina A., Gorbunov V.

卷 86, 编号 12 (2014)

Estimation of central blood pressure and arterial stiffness in pregnant women with different forms of hypertension

Chulkov V., Vereina N., Sinitsyn S., Dolgushina V.

卷 86, 编号 6 (2014)

Stakhova T., Shcherbak A., Kozlovskaia L., Taranova M., Balkarov I.

Peroxisome proliferator-activated receptors-γ and hypertension: Lessons of the history of researches

Rasin M.

The nature of a microcirculatory change in hypertensive patients during increased blood pressure

Vasil'ev A., Strel'tsova N., Sekisova M.

卷 85, 编号 3 (2013)

First clinical experience with endothelin receptor antagonist bosentan used in patients with pulmonary hypertension: results of a one-year study

Avdeev S., Tsareva N., Nekliudova G., Chuchalin A.

卷 84, 编号 12 (2012)

Cerebral blood flow and endothelial functional activity in patients with coronary heart disease and arterial hypertension during therapy with ivabradine in combination with perindopril

Musikhina N., Gapon L., Utesheva A., Petelina T., Kolesnikova S.

卷 84, 编号 4 (2012)

CURRENT APPROACHES TO ASSESSMENT OF LEFT VENTRICULAR HYPERTROPHY ASPECTS OF DIFFERENTIAL DIAGNOSIS

Saidova M.

卷 83, 编号 12 (2011)

Efficacy of hypobaric hypoxia in the treatment of arterial hypertension in postmenopausal women

Tin'kov A., Konstantinova O., Kshnyaseva S., Tinkov A., Konstantinova O., Kshnyaseva S.

卷 83, 编号 4 (2011)

Efficacy and safety of the first made in Russia alpha, beta long-acting adrenoblocker proxodolol in patients with arterial hypertension of the second degree

Belyaeva S., Belyaeva S.

卷 82, 编号 11 (2010)

Use of a nonselective endothelin receptor antagonist in idiopathic pulmonary hypertension

Arkhipova O., Martynyuk T., Lazutkina V., Ataullakhanova D., Stukalova O., Danilov N., Samoylenko L., Chazova I., Arkhipova O., Martynyuk T., Lazutkina V., Ataullakhanova D., Stukalova O., Danilov N., Samoilenko L., Chazova I.

卷 82, 编号 6 (2010)

Antihypertensive therapy optimization and endothelial function in patients with gout and chronic urate tubulointerstitial nephritis

Lebedeva M., Stakhova T., Zaitseva L., Selivanova O., Severova M.

卷 81, 编号 9 (2009)

Blood lipid spectrum in hypertensive patients and normotensive subjects living in the Khanty-Mansiysk region

Mikhaylova I., Gapon L., Belousov V., Startseva O., Alekseeva S., Mikhailova I., Gapon L., Belousov V., Startseva O., Alexeeva S.

卷 81, 编号 5 (2009)

Contribution of neurohumoral dysfunction and overweight to the course of essential hypertension

Bunova S., Bunova S.

卷 80, 编号 12 (2008)

Antihypertensive and organ-protective action of a 36-week monotherapy with telmisartan in hypertensive patients

Petriy V., Sergushkina N., Brazhnik V., Makolkin V., Petry V., Sergushkina N., Brazhnik V., Makolkin V.

卷 79, 编号 10 (2004)

Use of alpha-adrenoblockers intherapy of benign prostatic hyperplasia in patients with arterial hypertension

Mazo E., Shashin M.

Blockers of angiotensin receptors: a novel approach to treatment of secondary pulmonary hypertension

Butorov I., Verbitsky О., Butorov S.

卷 79, 编号 4 (2004)

Preclinical diagnosis of renal damage in essential hypertension

Grinstein Y., Shabalin V.

卷 78, 编号 11 (2003)

Comparative evaluation of cardiac hemodynamics and endothelium-dependent reactive hyperemia in arterial hypertension in those living in high-altitudeand plain areas

Doloman L., Beslaneev I., Batyrbekova L., Kurdanov K., Sagach V.

卷 78, 编号 3 (2003)

Pathogenesis of arterial hypertension within the metabolic syndrome

Ryazanov A., Arakelyants A., Yurenev A.

卷 78, 编号 4 (2003)

Leading trends in perfection of diagnosis and growing importance of invasive investigation methods

Gogin E.

卷 96, 编号 9 (2024): Кардиология

Metabolic disorders in patients with chronic thromboembolic pulmonary hypertension

Yarovoy S., Danilov N., Shchelkova G., Dinevich E., Mitrofanova A., Chazova I.

(Rus)

卷 94, 编号 9 (2022)

Ectopic obesity in patients without manifested cardiovascular disease: regulations, frequency and clinical characteristics

Podzolkov V., Bragina A., Osadchiy K., Rodionova Y., Djafarova Z., Khalenyan M., Dishkaya S.

(Rus)

卷 94, 编号 2 (2022)

CYP2D6 gene polymorphic markers role in determining the optimal treatment tactics for portal hypertension in patients with liver cirrhosis

Sychev D., Parusov A., Loranskaya I., Denisenko N., Akmalova K., Sozaeva Z., Turkina O., Zastrozhin M.

(Rus)

卷 93, 编号 9 (2021)

Optimization of specific therapy for pulmonary hypertension: the possibilities of riociguat

Martynyuk T., Shmalts A., Gorbachevsky S., Chazova I.

(Rus)

卷 93, 编号 4 (2021)

From palpation of the pulse to cuff-free methods: evolution of arterial pressure measurement methods

Solnceva T., Sivakova O., Chazova I.

(Rus)

卷 93, 编号 1 (2021)

Problems of insufficient control of target blood pressure levels in the outpatient practice

Larina V., Fedorova E., Mikhailusova M., Golovko M.

(Rus)

卷 92, 编号 1 (2020)

Hypertension and insomnia

Ostroumova T., Parfenov V., Ostroumova O., Kochetkov A.

(Rus)

Autoantibodies to M2-cholinoreceptors as a potential development factor of arrhythmia in patients with paroxysmal atrial fibrillation

Mironova E., Mironova N., Sharf T., Efremov E., Azmuko A., Molokoedov A., Zykov K., Golitsyn S.

(Rus)

卷 78, 编号 8 (2003)

Clinical efficiency and tolerance of hydrogensulfide balneotherapy in hypertensive patients living in theclimate of arid zone

Zunnunov Z.

Arterial hypertension at the workplace: risk factors and the population value

Strizhakov L., Babanov S., Lebedeva M., Moiseev S., Fomin V.

(Rus)

卷 91, 编号 2 (2019)

Non-alcoholic fatty liver disease as a cause and consequence of cardio-metabolic complications. Role of the ursodeoxicholic acid in the pharmacotherapy

Maevskaya M., Ivashkin V., Ivashkin K., Lunkov V., Liusina E., Zozula V., Leshchenko V.

(Rus)

卷 88, 编号 10 (2016)

Obesity in metabolic syndrome, as well as kidney dysfunction

Sadulaeva I., Vasyuk Y., Trofimenko O., Yushchuk E., Ivanova S., Shupenina E., Nesterova E.

(Rus)

Diagnosis and treatment of pulmonary hypertension: from the point of view of 2017

Sarybaev A., Sydykov A., Sartmyrzaeva M., Mamazhakypov A., Maripov A., Dzhumagulova A.

卷 89, 编号 9 (2017)

Genetic determinants of hypertension in two national cohorts of Mountain Shoria

Barbarash О., Voevoda М., Artamonova G., Mulerova Т., Voropaeva Е., Maksimov V., Ogarkov М.

(Rus)

卷 89, 编号 4 (2017)

Subtraction CT angiopulmonographic assessment of the vascular bed and lung perfusion in patients with chronic thromboembolic pulmonary hypertension: A pilot study

Veselova T., Demchenkova A., Martynyuk T., Danilov N., Ternovoy S., Chazova I.

(Rus)

卷 88, 编号 9 (2016)

Role of vascular remodeling markers in the development of osteoporosis in idiopathic pulmonary arterial hypertension

Nevzorova V., Kochetkova E., Ugay L., Maistrovskaya Y., Khludeeva E.

(Rus)

卷 88, 编号 6 (2016)

Risk factors for pulmonary hypertension at the predialysis stage of chronic kidney disease

Rudenko T., Vasilyeva M., Solomakhina N., Kutyrina I.

(Rus)

卷 87, 编号 6 (2015)

Hemodynamic effects of succinate-containing dialyzing solution

Smirnov A., Golubev R., Vasiliev A., Zemchenkov A., Staroselsky K.

卷 87, 编号 1 (2015)

Arterial hypertension: An expanding pathogenic continuum and therapeutic limitations

Kharchenko E.

卷 86, 编号 8 (2014)

Correction of endothelial dysfunction in hypertensive patients with type 2 diabetes mellitus during combined antihypertensive therapy

Statsenko M., Derevianchenko M.

卷 86, 编号 5 (2014)

The specific features of gout in the elderly

Tsurko V., Eliseeva M., Vorob'ev P.

What is the optimal choice of antihypertensive therapy based on: the class-specific effects or special properties of a drug?

Adasheva T., Samorukova E., Zadionchenko V., Nesterenko O.

On the way to achieve hypertension treatment goals: results of the open observational program AESCULAP (Exforge - Clinical safety and efficiency of using a double combination of antihypertensive drugs in patients with uncontrolled blood pressure)

Chazova I., Martyniuk T.

卷 85, 编号 1 (2013)

Effect of bosentan on the clinical status and cellular immunity of patients with idiopathic pulmonary hypertension

Martyniuk T., Zykov K., Antonova O., Rvacheva A., Arkhipova O., Kobal' E., Masenko V., Chazova I.

卷 84, 编号 9 (2012)

Radionuclide evaluation of renal function in essential hypertensive patients with chronic kidney disease

Musina N., Semenova R.

卷 84, 编号 3 (2012)

SECONDARY PULMONARY HYPERTENSION: SOME ASPECTS OF PATHOGENESIS

Neklyudova G., Avdeev S., Tsareva N., Chernyaev A., Samsonova M., Naumenko Z., Mikhale L.

卷 83, 编号 10 (2011)

Clinical implication of endothelial dysfunction in patients with essential arterial hypertension and urate dysbolism with renal damage

Stakhova T., Pulin A., Severova M., Shovskaya T., Minakova E., Oleynikova E., Lebedeva M., Stakhova T., Pulin A., Severova M., Shovskaya T., Minakova E., Oleinikova E., Lebedeva M.

卷 83, 编号 6 (2011)

Determination of urinary markers of proteolysis/fibrinolysis and fibroangiogenesis in the kidney in hypertensive patients

Nanchikeeva M., Kozlovskaya L., Rameev V., Fomin V., Bulanov N., Nanchikeeva M., Kozlovskaya L., Rameev V., Fomin V., Bulanov N.

卷 82, 编号 12 (2010)

Impact of antihypertensive therapy on clinical Status and quality of life in patients with initial manifestations of hypertensive encephalopathy

Varakin Y., Oshchepkova Z., Gornostaeva G., Amintaeva A., Kadykov A., Kravchenko M., Prokopovich M., Manvelov L., Suslina E., Varakin Y., Oshchepkova E., Gornostayeva G., Amintayeva A., Kadykov A., Kravchenko M., Prokopovich M., Manvelov L., Suslina Z.

卷 82, 编号 6 (2010)

Phosphorus and calcium metabolism and the cardiovascular system in patients with early-stage chronic renal disease

Smirnov A., Volkov M., Dobronravov V., Rafrafi H.

卷 81, 编号 8 (2009)

Hyperfiltration in hypertensive patients: results of epidemiological studies

Arutyunov G., Oganezova L., Arutyunov G., Oganezova L.

卷 81, 编号 6 (2009)

Neurohumoral regulation of blood pressure in rheumatic patients

Shilkina N., Stolyarova S., Yunonin I., Dryazhenkova I., Shilkina N., Stolyarova S., Dryazhenkova I.

卷 80, 编号 8 (2008)

Chronic obstructive pulmonary disease and associated illnesses

Chuchalin A.

卷 79, 编号 11 (2004)

Arterial hypertension in adolescents with different physical constitution including those with signs of metabolic syndrome

Rovda Y., Kazakova L., Rovda T., Rovda E.

Peculiarity of hypotensive efficacy in hypertensive patients with desaturation signs of obstructive sleep apnea syndrome

Zelveian I., Oschepkova E., Buniatian M., Rogoza A.

Outlook from the past to the future

Chazov E.

卷 78, 编号 12 (2003)

Nifedipine-retard alone and incombination with metoprolol: comparative efficacy andsafety in patients with arterial hypertension

Isaikina O., Gorbunov V., Andreeva G., Dmitrieva N., Martsevich S.

卷 78, 编号 6 (2003)

Arterial hypertension, its metabolic aspects and function of the kidneys inconvalescents after hemorrhagic fever with renal syndrome

Pimenov L., Dudarev M., Vasilyev M.

卷 96, 编号 9 (2024): Кардиология

Antihypertensive therapy in patients with arterial hypertension and concomitant diseases in real clinical practice (according to the National Registry of Arterial Hypertension, 2019–2022)

Aksenova A., Oschepkova E., Chazova I.

(Rus)

卷 94, 编号 12 (2022)

Hyperuricemia and kidney damage in patients with cardiovascular disease: A review

Mironova O.

(Rus)

卷 94, 编号 1 (2022)

Primary hyperaldosteronism: indications for screening

Chikhladze N.

(Rus)

卷 93, 编号 4 (2021)

Features of antihypertensive therapy and real-world prescription of selective imidazoline receptor agonists in Russia vs other countries: STRAIGHT study data analysis

Konradi A., Zvartau N., Chazova I., Zhernakova J., Schutte A., Schlaich M.

(Rus)

卷 92, 编号 9 (2020)

COVID-19 and cardiovascular diseases

Chazova I., Mironova O.

(Rus)

卷 92, 编号 1 (2020)

Assessment of the clinical efficacy of telemonitoring and distant counseling in patients with uncontrolled hypertension

Ionov M., Zhukova O., Zvartau N., Kurapeev D., Yudina Y., Konradi A.

(Rus)

卷 78, 编号 8 (2003)

Diroton effects on 24-h fluctuations of arterial pressure as shown bymonitoring in hypertensive patients with polycythemia vera

Gorokhovskaya G., Zavyalova A., Martynov A.

Worksite hypertension as a model of stress-induced arterial hypertension

Ostroumova O., Kochetkov A.

(Rus)

(Rus)

卷 91, 编号 2 (2019)

Risk factors associated with portal vein thrombosis in liver cirrhosis: A case-control study

Nadinskaia M., Kodzoeva K., Ulyanova K., Rogacheva S., Volkova A., Dekhanov A., Strelkova D., Ivashkin V.

(Rus)

(Eng)

卷 90, 编号 2 (2018)

Comorbid for gastroduodenal ulcers in the aspect of calcium imbalance and blockers of slow calcium channels in their treatment

Fomina L.

(Rus)

卷 88, 编号 10 (2016)

Clinical guidelines for the diagnosis and treatment of chronic thromboembolic pulmonary hypertension (Part 2)

Chazova I., Martynyuk T.

(Rus)